CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 4 Grant or award Chief Commercial Officer acquired 62,500 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 375,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 62,500 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 62,500 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 100,000 shares (grant or award)
- 8-K Event Regulation FD disclosure · Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Grant or award Director acquired 4,666 shares (grant or award)
- 4 Grant or award Director acquired 4,666 shares (grant or award)
- 4 Grant or award Director acquired 4,666 shares (grant or award)
- 4 Grant or award Director acquired 4,666 shares (grant or award)
- 4 Grant or award Director acquired 3,555 shares (grant or award)
- 4 Grant or award Director acquired 4,666 shares (grant or award)
Page 3 of 26 · 506 filings